
A Phase I Study of Irinotecan, Capecitabine (Xeloda), and Oxaliplatin in Patients With Advanced Colorectal Cancer
Keywords: Advanced CRC; IXO regimen; Metastatic colorectal cancer; Phase 1; Triple combination;